V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002092 | 230004548 | 1.64 | 70.1 | null | 2017-08-14 | 2017-08-26 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100758939 |
| 230002093 | 230004549 | 1.63 | 82.6 | Palliative (P) | 2015-06-14 | 2016-09-12 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101534372 |
| 230002097 | 230004553 | 1.63 | 43.2 | null | 2016-12-14 | 2016-12-14 | null | null | null | CISPLATIN | 100918154 |
| 230002098 | 230004554 | null | null | null | 2017-12-16 | 2017-12-27 | Rucaparib | 02 | null | RUCAPARIB | 101686199 |
| 230002099 | 230004555 | null | null | null | 2020-07-03 | 2020-07-04 | PACLITAXEL | 02 | null | PACLITAXEL | 100874447 |
| 230002100 | 230004556 | 1.61 | 72.3 | null | 2018-10-15 | 2018-10-17 | null | null | null | LIPOSOMAL DOXORUBICIN | 100793889 |
| 230002102 | 230004558 | 1.7 | 118.4 | null | 2018-11-21 | 2018-12-05 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101463180 |
| 230002103 | 230004559 | null | null | Palliative (P) | null | 2017-05-26 | Rucaparib | 02 | N | RUCAPARIB | 100948984 |
| 230002105 | 230004561 | 1.63 | 78.5 | null | 2020-01-08 | 2020-01-15 | null | null | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100862708 |
| 230002109 | 230004565 | 1.49 | 62.8 | null | null | 2018-10-31 | null | null | null | INTERLACE TRIAL | 100812027 |
| 230002111 | 230004567 | 1.63 | 61 | null | null | 2019-11-17 | null | 99 | null | LIPOSOMAL DOXORUBICIN | 101356988 |
| 230002112 | 230004568 | 1.72 | 70.9 | null | 2017-11-22 | 2017-11-27 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101610339 |
| 230002115 | 230004571 | null | null | Palliative (P) | null | 2019-03-06 | Olaparib | 02 | null | OLAPARIB | 100114246 |
| 230002116 | 230004572 | 1.58 | 91.5 | Palliative (P) | 2020-02-24 | 2020-02-26 | null | 02 | N | TRIAL UNSPECIFIED | 100762399 |
| 230002118 | 230004574 | 1.67 | 62.7 | null | null | 2016-12-13 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100138953 |
| 230002121 | 230004576 | null | null | null | 2020-01-24 | 2020-02-06 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100231171 |
| 230002123 | 230004578 | 1.63 | 0 | null | null | 2019-04-25 | null | null | null | OLAPARIB | 100941032 |
| 230002124 | 230004579 | 1.7 | 69.8 | null | 2020-02-22 | 2020-02-22 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100318201 |
| 230002126 | 230004581 | 1.68 | 50.3 | Curative (C) | 2019-09-11 | 2019-09-12 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101602613 |
| 230002127 | 230004582 | null | null | null | null | 2019-02-05 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101755948 |
| 230002128 | 230004583 | 1.52 | 56.15 | null | null | 2019-08-20 | PACLITAXEL | 02 | null | PACLITAXEL | 100303037 |
| 230002129 | 230004584 | null | null | null | 2018-02-12 | 2018-02-19 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101432037 |
| 230002130 | 230004585 | 1.68 | 115.9 | null | null | 2019-03-28 | null | 02 | null | FLUOROURACIL + OXALIPLATIN | 100943287 |
| 230002132 | 230004587 | 1.58 | 89.5 | null | 2019-01-17 | 2019-06-15 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101691266 |
| 230002133 | 230004588 | null | null | null | 2019-04-03 | 2019-04-05 | Bevacizumab | 02 | null | BEVACIZUMAB | 100173634 |
| 230002134 | 230004589 | 1.74 | 41 | null | 2019-10-03 | 2021-04-09 | PACLITAXEL | 02 | null | PACLITAXEL | 100359729 |
| 230002135 | 230004590 | null | null | null | null | 2016-11-20 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101119295 |
| 230002136 | 230004591 | null | null | Palliative (P) | 2020-08-14 | 2020-08-19 | null | null | N | PEMBROLIZUMAB | 100984193 |
| 230002137 | 230004592 | 1.76 | 58 | null | null | 2019-07-13 | Niraparib | 02 | null | NIRAPARIB | 101670470 |
| 230002138 | 230004593 | 1.47 | 98.8 | Palliative (P) | null | 2019-12-11 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100730537 |
| 230002139 | 230004594 | null | null | 03 | null | 2019-03-07 | null | null | N | BEVACIZUMAB | 100761734 |
| 230002141 | 230004595 | 1.56 | 77.4 | null | 2021-10-24 | 2021-11-01 | null | null | null | PACLITAXEL | 101257171 |
| 230002142 | 230004596 | 1.63 | 66.7 | null | null | 2019-07-10 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100691500 |
| 230002143 | 230004597 | null | null | Palliative (P) | null | 2019-09-15 | Olaparib | 02 | N | OLAPARIB | 100118813 |
| 230002146 | 230004599 | 1.57 | 89.5 | null | 2021-09-30 | 2021-10-06 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100649868 |
| 230002147 | 230004600 | null | null | Palliative (P) | 2020-05-01 | 2020-05-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101251132 |
| 230002148 | 230004601 | null | null | Neo-adjuvant (N) | 2019-10-23 | 2019-10-23 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101606687 |
| 230002151 | 230004604 | null | null | null | null | 2022-01-09 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100520822 |
| 230002152 | 230004605 | 1.48 | 104 | Palliative (P) | 2019-03-10 | 2019-03-25 | Olaparib | 02 | N | OLAPARIB | 101124121 |
| 230002153 | 230004606 | 1.79 | 47.9 | null | 2019-08-13 | 2019-08-14 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100775832 |
| 230002155 | 230004608 | 1.6 | 100 | null | 2020-08-09 | 2020-08-15 | null | 01 | null | CARBOPLATIN | 100429798 |
| 230002158 | 230004610 | 1.73 | 101 | null | 2020-11-17 | 2020-12-15 | Bevacizumab | 02 | null | BEVACIZUMAB | 100331492 |
| 230002160 | 230004612 | null | null | Adjuvant (A) | 2019-09-08 | 2019-09-14 | null | Y | N | CISPLATIN + ETOPOSIDE | 100358699 |
| 230002161 | 230004613 | null | 69.6 | null | 2022-01-22 | 2022-01-22 | Niraparib | 02 | null | NIRAPARIB | 101013532 |
| 230002162 | 230004614 | null | null | null | null | 2019-10-28 | Cisplatin + Doxorubicin | 02 | null | CISPLATIN + ETOPOSIDE | 101514093 |
| 230002163 | 230004615 | null | null | Palliative (P) | 2018-01-30 | 2018-07-02 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101233285 |
| 230002164 | 230004616 | 1.6 | 61.5 | Palliative (P) | null | 2019-07-25 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100317806 |
| 230002168 | 230004619 | null | null | null | 2019-03-07 | 2019-05-16 | null | null | null | OLAPARIB | 100466615 |
| 230002171 | 230004622 | 1.62 | 42 | null | 2020-03-01 | 2020-03-02 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100403459 |
| 230002173 | 230004624 | null | null | null | null | 2019-02-27 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101098825 |